France seeks to house European Medicines Agency in wake of Brexit

Officials from the cities of Strasbourg and Lyon want France to be the new headquarters of the European Medicines Agency following Britain’s vote to leave the European Union, according to Reuters.

Advertisement

The EMA, which is the EU’s equivalent to the Food and Drug Administration, is currently located in London. The agency is expected to have to relocate due to Britain’s exit from the EU.

Philippe Richert, president of Grand Est regional council in eastern France, asked French President Francois Hollande to nominate Strasbourg as the new location for the EMA.

European lawmaker Françoise Grossetete requested that the EMA move to Lyon since several drug companies, including Sanofi, are based there.

These aren’t the first cities to put their hats into the ring — Milan, Madrid, Stockholm, Warsaw and Vienna have all expressed interest in being the new home of the EMA, acknowledging the advantage of having close ties with the regulator.

More articles on supply chain:

Blood banks hit by Zika donor rules, leaving some regions in critical shortage
FDA approves Abbott’s fully dissolving heart stent
Pfizer agrees to acknowledge addiction risks in opioid marketing

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.